Drug Discovery Outsourcing Market Report 2026

Drug Discovery Outsourcing Market Overview

• Drug Discovery Outsourcing market size has reached to $4.24 billion in 2025 • Expected to grow to $6.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Chronic Diseases Propel Growth Of The Drug Discovery Outsourcing Market • Market Trend: Innovation Surge In Drug Discovery Outsourcing With Launch Of New Digital Health Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Discovery Outsourcing Market?

Drug discovery outsourcing refers to the practice of pharmaceutical companies contracting external organizations to conduct various stages of the drug discovery process, such as target identification, lead optimization, and preclinical testing, to leverage specialized expertise, reduce costs, and accelerate development timelines. The main types of drug discovery outsourcing are chemistry services and biological services. Chemistry services in drug discovery outsourcing involve providing specialized chemical expertise, such as synthesis, analysis, and optimization of drug candidates. The workflow includes target identification and screening, target validation and functional informatics, lead identification and candidate optimization, preclinical development, and others. Disease models used include in vitro models, animal models, cellular models, and others. These services support various therapeutic areas such as cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory system, infectious disease, oncology, immunology, and others and are used by several end users, including pharmaceutical and biotechnology companies, academic institutes, and others.

What Is The Drug Discovery Outsourcing Market Growth Forecast?

The drug discovery outsourcing market size is expected to see strong growth in the next few years. It will grow to $6.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled drug discovery tools, rising focus on rare and complex disease research, expansion of personalized medicine development, growing investment in outsourced innovation models, increasing globalization of pharmaceutical r&d. Major trends in the forecast period include increasing adoption of integrated drug discovery service models, rising demand for end-to-end preclinical outsourcing, growing use of advanced screening platforms, expansion of specialized cro capabilities, enhanced focus on accelerated development timelines.

Global Drug Discovery Outsourcing Market Segmentation

1) By Service Type: Chemistry Services, Biological Services 2) By Workflow: Target Identification And Screening, Target Validation And Functional Informatics, Lead Identification And Candidate Optimization, Preclinical Development, Other Workflows 3) By Disease Model: In Vitro Models, Animal Models, Cellular Models, Other Disease Models 4) By Therapeutic Area: Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Other Therapeutic Areas 5) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users Subsegments: 1) By Chemistry Services: Custom Synthesis And Manufacturing, Medicinal Chemistry, Combinatorial Chemistry, Hit Identification And Lead Optimization, Process Chemistry And Scale-Up, Analytical Chemistry Services, Chemical Library Design And Screening, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling 2) By Biological Services: Cell-Based Assays And Screening, Target Identification And Validation, In Vitro And In Vivo Testing, Biomarker Discovery And Development, Toxicology Studies, Genomics And Proteomics Services, Animal Models For Preclinical Development, Biological Safety And Efficacy Testing, Biopharmaceutical Development And Manufacturing.

What Is The Driver Of The Drug Discovery Outsourcing Market?

The growing prevalence of chronic diseases is expected to propel the growth of the drug discovery outsourcing market going forward. Chronic diseases are long-lasting health conditions that persist over time, often for years or even a lifetime. Chronic diseases are rising due to several reasons, including an aging population, lifestyle choices, urbanization, and environmental factors. Drug discovery outsourcing accelerates the development of treatments for chronic diseases by providing access to specialized expertise and advanced technologies, reducing time and costs. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based federal health agency, in 2023 approximately 194 million U.S. adults (76.4 %) reported having one or more chronic conditions, and about 130 million adults (51.4 %) reported having multiple chronic conditions Therefore, the growing prevalence of chronic diseases is driving the growth of the drug discovery outsourcing industry.

Key Players In The Global Drug Discovery Outsourcing Market

Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited

Global Drug Discovery Outsourcing Market Trends and Insights

Major companies operating in the drug discovery outsourcing market are focusing on developing innovations, such as digital health solutions, to better meet the needs of healthcare professionals, regulators, and patients. Digital health solutions encompass technologies and services, such as telemedicine, mobile health apps, and wearable devices, that enhance healthcare delivery, patient engagement, and health management. For instance, in November 2023, AstraZeneca PLC, a UK-based biopharmaceutical company, launched Evinova, a cutting-edge health-tech business dedicated to advancing innovation in the life sciences sector and enhancing the delivery of clinical trials. With a focus on improving health outcomes, it aims to offer globally-scaled digital products and services that have already proven effective in AstraZeneca's clinical trials across more than 40 countries. By optimizing clinical trial design and delivery, Evinova seeks to streamline the process of developing new medicines, ultimately reducing both time and costs.

What Are Latest Mergers And Acquisitions In The Drug Discovery Outsourcing Market?

In July 2024, Selvita SA, a Poland-based company that provides drug discovery, research, and development services, acquired PozLab for an undisclosed amount. This strategic acquisition significantly enhances capabilities in drug development, positioning the company as a comprehensive solution provider in the pharmaceutical industry and enabling the offering of small molecule drug manufacturing services for early-stage clinical trials. PozLab is a Poland-based contract development organization that provides end-to-end pharmaceutical development services.

Regional Outlook

North America was the largest region in the drug discovery outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Discovery Outsourcing Market?

The drug discovery outsourcing market includes revenues earned by entities by providing services such as trial design, site management, patient recruitment, and data collection and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Discovery Outsourcing Market Report 2026?

The drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.